Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

AGGF1 antibody

AGGF1 Reactivity: Human WB, IP, IHC (fro), IHC (p), EIA Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN1105264
  • Target See all AGGF1 Antibodies
    AGGF1 (Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1))
    Reactivity
    • 40
    • 26
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 58
    • 4
    Rabbit
    Clonality
    • 61
    • 2
    Polyclonal
    Conjugate
    • 35
    • 6
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This AGGF1 antibody is un-conjugated
    Application
    • 57
    • 22
    • 16
    • 13
    • 13
    • 10
    • 6
    • 6
    • 4
    • 4
    • 3
    • 2
    • 1
    Western Blotting (WB), Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
    Specificity
    The antibody reacts with human VG5Q, a 84 kDa protein.
    Cross-Reactivity (Details)
    Species reactivity (tested):Human
    Purification
    Protein A
    Immunogen
    VG5Q functions as an angiogenic factor in promoting angiogenesis and suppression of VG5Q expression inhibits vessel formation. Angiogenic factors are critical to the initiation of angiogenesis and maintenance of the vascular network. Angiogenesis has an essential role in pathological conditions such as cancer and various ischaemic and inflammatory diseases. VG5Q can bind to endothelial cells and promote cell proliferation, suggesting that the protein may act in an autocrine fashion. VG5Q interacts with TWEAK (also known as TNFSF12), another secreted angiogenic factor. VG5Q shows strong expression in blood vessels and is secreted when vessel formation is initiated. VG5Q protein was detected mostly in the cytoplasm and around the nuclei of human microvascular endothelial cells (HMVECs). Furthermore VG5Q is detected in human umbilical vein endothelial cells (HUVECs), human heart fibroblast (HHF) and ovarian cancer cells (OV-3), but low expression was detected in kidney cancer cells (RP-45), HeLa Cells and bladder cancer cells.
    Isotype
    IgG
    Top Product
    Discover our top product AGGF1 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    0.1 mg/mL
    Buffer
    PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C
    Storage Comment
    Store at 2 - 8 °C.
  • Target
    AGGF1 (Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1))
    Alternative Name
    AGGF1 / VG5Q (AGGF1 Products)
    Synonyms
    RGD1310888 antibody, AGGF1 antibody, LOC100037685 antibody, im:7146636 antibody, zgc:152959 antibody, DKFZp459G1317 antibody, GPATC7 antibody, GPATCH7 antibody, HSU84971 antibody, HUS84971 antibody, VG5Q antibody, 2010009L17Rik antibody, 2310029P06Rik antibody, AW112072 antibody, Peg3 antibody, angiogenic factor with G patch and FHA domains 1 antibody, angiogenic factor with G-patch and FHA domains 1 antibody, Aggf1 antibody, AGGF1 antibody, aggf1 antibody, CC1G_06398 antibody
    Background
    Synonyms: Angiogenic factor VG5Q, Angiogenic factor with G patch and FHA domains 1, G patch domain-containing protein 7, GPATC7, GPATCH7, Vasculogenesis gene on 5q protein
    Gene ID
    55109
    NCBI Accession
    NP_060516
    UniProt
    Q8N302
You are here:
Support